Policies Supporting Vaccine-like Preventative Products
Virtual
Tuesday, January 30, 2024
3:00 PM - 4:30 PM
Eastern Standard Time
Recently, a respiratory syncytial virus (RSV) monoclonal antibody was approved by the Advisory Committee on Immunization Practices (ACIP) to protect against severe illness in infants under eight months of age. This learning community session will focus on state policy opportunities to support greater access to RSV preventative antibody products. After hearing from experts, participants will discuss challenges and opportunities when including the new preventative antibody products in their state childhood vaccine programs. Following this session, participants will have a better understanding of the various policy options and peer strategies to expand access to preventative antibody products.
Featured Speakers:
- Maggie Davis, JD, MA Director, State Health Policy at ASTHO
- Rebecca Coyle, MEd, Executive Director at AIRA
- Brent Ewig, MHS, Chief Policy & Government Relations Officer at Association of Immunization Managers